-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Pyxis Oncology, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q3 2020 to Q3 2025.
- Pyxis Oncology, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2025 was $1.46M, a 42.8% decline year-over-year.
- Pyxis Oncology, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2025 was $7.23M, a 26.3% decline year-over-year.
- Pyxis Oncology, Inc. annual Nonoperating Income (Expense) for 2024 was $9.97M, a 18.5% increase from 2023.
- Pyxis Oncology, Inc. annual Nonoperating Income (Expense) for 2023 was $8.41M, a 204% increase from 2022.
- Pyxis Oncology, Inc. annual Nonoperating Income (Expense) for 2022 was $2.76M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)